Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

JAMA Dermatology
Mina S AllyA Dimitrios Colevas

Abstract

Tumor resistance is an emerging problem for Smoothened (SMO) inhibitor-treated metastatic basal cell carcinoma (BCC). Arsenic trioxide and itraconazole antagonize the hedgehog (HH) pathway at sites distinct from those treated by SMO inhibitors. To determine whether administration of intravenous arsenic trioxide and oral itraconazole in patients with metastatic BCC is associated with a reduction in GLI1 messenger RNA expression in tumor and/or normal skin biopsy samples. Five men with metastatic BCC who experienced relapse after SMO inhibitor treatment underwent intravenous arsenic trioxide treatment for 5 days, every 28 days, and oral itraconazole treatment on days 6 to 28. Data were collected from April 10 to November 14, 2013. Follow-up was completed on October 3, 2015, and data were analyzed from June 5 to October 6, 2015. The primary outcome was the change in messenger RNA levels of the GLI family zinc finger 1 (GLI1) gene (HH-pathway target gene) in biopsy specimens of normal skin or BCC before and after treatment. Secondary objectives were evaluation of tumor response and tolerability. Of the 5 patients (mean [SD] age, 52 [9] years; age range, 43-62 years), 3 completed 3 cycles of treatment and 2 discontinued treatment ea...Continue Reading

Citations

Aug 25, 2016·Hereditary Cancer in Clinical Practice·Aglaya G Iyevleva, Evgeny N Imyanitov
Jul 28, 2016·The Journal of Investigative Dermatology·Sarah K WhitleyJay K Kolls
Sep 17, 2016·Expert Review of Anticancer Therapy·Nicholas J CollierJohn T Lear
Aug 24, 2017·Plastic and Reconstructive Surgery. Global Open·Kai Yuen WongAmer J Durrani
Sep 10, 2017·American Journal of Clinical Dermatology·Rebecca DanhofMariah Brown
Jan 10, 2018·Medicinal Research Reviews·Minhang XinBinghe Wang
Apr 27, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Miroslava DidiasovaMalgorzata Wygrecka
Aug 31, 2018·International Journal of Molecular Sciences·Maja SabolSonja Levanat
Sep 17, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M NikanjamR Kurzrock
Jan 17, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Richard L Carpenter, Haimanti Ray
May 13, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mayukh BanerjeeElaine M Leslie
Sep 21, 2017·Oncology Letters·Rachel PoundsSean Kehoe
Aug 20, 2020·JCO Oncology Practice·Magdalena CiążyńskaAleksandra Lesiak
Mar 29, 2020·Journal of Clinical Pathology·Qisi SunKeith A Choate
Jul 28, 2017·Scientific Reports·Chel Hun ChoiJeong-Won Lee
Apr 5, 2018·Journal of Developmental Biology·Yoshinori Abe, Nobuyuki Tanaka
Dec 4, 2019·Nature Reviews. Clinical Oncology·Joseph A ClaraNaoko Takebe
Jun 28, 2019·Targeted Oncology·Ralf Gutzmer, James A Solomon
Nov 28, 2019·Current Treatment Options in Oncology·Erica LeavittStephanie Martin
Mar 8, 2017·Proceedings of the National Academy of Sciences of the United States of America·Elena KamyninaPatrick J Stover
Apr 18, 2017·Cell & Bioscience·Lining ZhangJingwu Xie
Feb 8, 2020·Indian Journal of Dermatology·José-Francisco Millán-CayetanoMagdalena de Troya-Martin
Sep 24, 2020·Journal of Clinical Medicine·Mircea TampaMonica Neagu
Nov 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nicholas J Collier, Lesley E Rhodes
May 22, 2018·Journal of the American Academy of Dermatology·Michael C CameronAnthony M Rossi
Oct 24, 2020·International Journal of Molecular Sciences·Mariana NunesSara Ricardo
Apr 26, 2021·Current Problems in Cancer·Diya M SabuFergal C Kelleher
Jun 24, 2021·The Australasian Journal of Dermatology·Ken Hiu-Kan Ip, Kevin McKerrow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

© 2022 Meta ULC. All rights reserved